COMMUNIQUÉS West-GlobeNewswire

IBA – TRANSPARENCY NOTIFICATION
12/01/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 12, 2026 10:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025
12/01/2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Avertissement : Le présent [...]
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
12/01/2026
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Notice: This [...]
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
12/01/2026
WESTLAKE VILLAGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation ( NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the [...]
SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
12/01/2026
TEL AVIV, Israel, Jan. 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary [...]
Crinetics Pharmaceuticals Announces January 2026 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/01/2026
SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2026, the Compensation Committee of the Board of Directors granted non-qualified stock [...]
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes
12/01/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. DUBLIN, Jan. 12, [...]
Nyxoah Annonce ses Résultats Préliminaires pour le Quatrième Trimestre et l'Ensemble de l'Exercice 2025 et Communique des Prévisions de Chiffre d'Affaires pour le Premier Trimestre 2026
12/01/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce ses Résultats Préliminaires pour le Quatrième Trimestre et l'Ensemble de l'Exercice 2025 et Communique des Prévisions de Chiffre d'Affaires pour le [...]
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
12/01/2026
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 Strong Start in First Full Quarter of U [...]
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
12/01/2026
NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Ellen Rose, the new Senior Vice President, Corporate [...]
SafeSpace Global Corporation (OTCID: SSGC) Issues CEO Letter to Shareholders
12/01/2026
Knoxville, TN, Jan. 12, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC), a leading AI technology company delivering multimodal safety solutions across education, healthcare, transportation, and [...]
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
12/01/2026
- Preliminary unaudited Q4 and Full Year 2025 net Attruby ® product revenue of $146.0 million and $362.4 million, respectively - Attruby (acoramidis) is rapidly becoming the first-choice therapy for newly diagnosed ATTR [...]
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
12/01/2026
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA 1 Biogen is dedicated to [...]
Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir® platform.
12/01/2026
Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir® platform. San Diego, United-States and Paris, France – [...]
SAFE GROUP NOMME CYRIL GONCALVES AU POSTE DE DIRECTEUR ADMINISTRATIF ET FINANCIER
12/01/2026
SAFE GROUP NOMME CYRIL GONCALVES AU POSTE DE DIRECTEUR ADMINISTRATIF ET FINANCIER Renforcement de l’équipe de direction Fleurieux-sur-l’Arbresle – France – 12 janvier 2026 – 18h - Safe (FR001400ZU25 – ALSAF), annonce [...]
IBA SA – NOTIFICATION TRANSPARENCE
12/01/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 12 janvier 2026, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le [...]
IBA – TRANSPARENCY NOTIFICATION
12/01/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 12, 2026 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
Nudj Health Names Dr. David Nash
12/01/2026
Global leader of Population Health and Public Accountability for Health Outcomes Joins Advisory Board SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- JP Morgan Healthcare Conference -- Nudj Health, the leading AI- [...]
Sorevna Announces Strategic Expansion into Bath and Body Sector
12/01/2026
New York, USA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sorevna , a company in the cosmetics industry, today announced its planned entry into the bath and body care segment, expanding its existing product portfolio. The [...]

Pages